Stay updated on Nivolumab for Peripheral T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.
Latest updates to the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information have been removed.SummaryDifference6%
- Check40 days agoChange DetectedNew entries for Dendritic Cell Tumor and Blastic Plasmacytoid Dendritic Cell have been added, while numerous links related to various lymphomas and genetic conditions have been removed.SummaryDifference1%
- Check48 days agoChange DetectedThe website has been updated to include numerous new links related to genetics and various lymphomas, as well as a new version revision (v2.12.2), replacing the previous version (v2.12.1).SummaryDifference4%
- Check55 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.4%
Stay in the know with updates to Nivolumab for Peripheral T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.